Target intelligence / Profile preview

Messenger RNAs bearing miR-148a-5p seed-complementary sites (miR-148a-5p targets)

Target
miR-148a-5p targets
Molecular classification
Nucleic acid, Messenger RNA
01

Overview

Messenger RNAs (mRNAs) bearing miR-148a-5p seed-complementary sites represent the collective group of transcripts post-transcriptionally regulated by the microRNA miR-148a-5p. These mRNAs contain specific sequences, typically in their 3' untranslated regions (UTRs), that pair with the 5' 'seed' region of the miRNA, facilitating binding by the RNA-induced silencing complex (RISC) (PMID: 21454424). This interaction leads to gene silencing through either mRNA degradation or the inhibition of protein translation. miR-148a-5p is a critical regulator of diverse biological processes, including DNA methylation via its targeting of DNMT1 and apoptosis via BCL2 (PMID: 24607418). In various malignancies, such as hepatocellular and gastric carcinomas, miR-148a-5p often acts as a tumor suppressor; its downregulation leads to the pathological overexpression of these target mRNAs, promoting cell proliferation and metastasis (PMID: 24333734). Therapeutic intervention typically involves the use of miRNA mimics to restore the silencing of these mRNAs or antagomirs to inhibit miRNA activity in specific disease contexts. However, because a single miRNA can regulate hundreds of different mRNAs simultaneously, achieving high therapeutic specificity without off-target effects remains a significant challenge in drug development (PMID: 23873015).

Other names
miR-148a-5p target transcriptsmiR-148a-5p regulated mRNAsMicroRNA-148a-5p target geneshsa-miR-148a-5p targets
02

Mechanism of action

miRNA mimics bind to these mRNA sites to induce translational repression or mRNA cleavage via the RISC complex, while antagomirs prevent endogenous miRNA binding to de-repress the target mRNAs.

03

Biological functions

Post-transcriptional gene regulationGene silencingTranslation inhibitionmRNA degradation
04

Disease associations

CancerHepatocellular carcinomaGastrointestinal cancerAutoimmune diseaseCardiovascular diseaseInflammation
05

Safety considerations

Off-target hybridizationInnate immune response to double-stranded RNASaturation of the cellular RNAi machineryDelivery-related toxicity
06

Interacting drugs

miR-148a-5p mimics

1 more in the full profile.

07

Biomarkers

miR-148a-5p expression levelsDNMT1 protein levelsBCL2 protein levelsCirculating miR-148a-5p

Beyond the preview

Go deeper on Messenger RNAs bearing miR-148a-5p seed-complementary sites (miR-148a-5p targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Messenger RNAs bearing miR-148a-5p seed-complementary sites (miR-148a-5p targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call